CORONAVIRUS NEWS

Over the past 12 months, Menarini Diagnostics has brought to market a range of new and innovative technologies to aid in the global fight against Covid-19. The company is now pleased to support this week’s BSMT webinar series on COVID-19.

This British Society for Microbial Technology (BSMT) webinar series of lectures is recorded, so registrants can view either in real time or after the event when convenient to do so.

The VITROS COVID-19 Total and IgG Antibody Tests and VITROS SARS-CoV-2 Antigen Test from Ortho Clinical Diagnostics help to identify an active or previous infection, together with PCR and clinical history.

A team of scientists at the University of Glasgow has identified two known cases of human-to-cat SARS-CoV-2 transmission in the UK.

The Native Antigen Company has launched its SARS-CoV-2 Neutralisation Assay Development Kit, which can be used to identify and qualitatively assess the ability of antibodies to neutralise SARS-CoV-2-receptor binding.

Bio-Rad Laboratories has launched the SARS-CoV-2 Variant RT-PCR assays, which can detect the variants of concern, including P.1, B.1.351, and B.1.1.7.

All ViroStat COVID-19 monoclonal antibodies are validated to react with the nucleocapsid of common variants circulating, including UK B.1.1.7, South Africa B.1.351 and Brazil P.1, ensuring that the variants will be detected with these antibodies.

A new international study has provided a template for how to develop directly-acting antivirals with novel modes of action, that would combat COVID-19 by suppressing the SARS-CoV-2 viral infection.

The BSMT has confirmed that Professor Sheena Cruikshank (University of Manchester) will speak on 'From Variola to COVID-19: the Development of Modern Vaccines'. Click on this news item for the link to register for this FREE-to-attend webinar series.

The British Society for Microbial Technology event takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for this FREE-to-attend webinar series.

Mologic, a developer of lateral-flow and rapid diagnostics, has announced its rapid antigen self-test for SARS-CoV-2 has been selected by the Rapid Acceleration of Diagnostics (RADx) initiative launched by the US National Institutes of Health (NIH).

Avacta Group, the developer of cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, has announced a global distribution agreement with ABCAM to sell the SARS-CoV-2 research ELISA Affimer reagents.

The BSMT Virtual Conference on COVID-19 is a FREE-to-attend event that takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for the webinar series.

Thermo Fisher Scientific and Artificial, a developer of flexible automation software, have announced a technology collaboration to develop an integrated and comprehensive software platform for Thermo Fisher’s standardised COVID-19 Testing Platform.

This British Society for Microbial Technology (BSMT) virtual conference, held in conjunction with media partner Pathology in Practice, on 11–14 May, will be sponsored by 22 companies.

IONTAS and FairJourney Biologics have announced the identification of neutralising antibodies, which bind to multiple emerging SARS-CoV-2 variants.

Beckman Coulter today has expanded claims for its CE-marked Access Interleukin-6 (IL-6) assay, an in vitro diagnostic test for the quantitative determination of IL-6 levels in human serum and plasma.

Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has announced a commercial partnership with Mologic, a developer and manufacturer of lateral-flow and rapid diagnostic tests.

Additions to the programme and sponsors for this important British Society for Microbial Technology (BSMT) virtual conference, which will be held on 11–14 May, have now been released. See the following for the latest details…

The British Society for Microbial Technology (BSMT) will hold a virtual conference entitled ‘COVID-19 – The Infection Challenging the World' over four days in May. Click on this story for current details of the programme and commercial support.